Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients
This phase I/II trial studies how well patient portal and navigation program work in providing information for Asian American cancer patients. Patient portal and navigation program may help to improve the care provided to Asian American cancer patients.This study is offered in the following languages in addition to English: Chinese (Cantonese or Mandarin) and Vietnamese.
Checked against the public recordLast updated Jan 12, 2023 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of California, San Francisco
- Interventions being studied
- Behavioral: Patient Navigation Program; Other: Quality-of-Life Assessment; Other: Survey Administration
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * FOR INTERVIEWS AND FOCUS GROUPS: * Cancer patients: Self-identifies as Asian American, lives in San Francisco, speaks English, Mandarin, Cantonese, or Vietnamese, has a history of cancer of any kind * Caregivers: any person age 21 and older who has provided care to an Asian American cancer patient * Health professionals: physicians and other health professionals age 21 and older who provide care to Asian American patients with cancer * FOR PILOT IMPLEMENTATION: * Self-identifies as Asian American * Ages 21 or older * Lives in the 9 counties of the greater bay area cancer registry (GBACR) * Speaks English, Mandarin, Cantonese, or Vietnamese * Has any stage colorectal, lung, or liver cancer * Has not started treatment or has not completed treatment * Is willing to stay in the study for six months. * FOR FULL IMPLEMENTATION: * Self-identifies as Asian American * Ages 21 or older * Lives in the 9 counties of the GBACR * Speaks English, Mandarin, Cantonese, or Vietnamese * Has any stage colorectal, lung, or liver cancer, * Has not started or has not completed treatment * Is willing to stay in the study for six-seven months Exclusion Criteria: \*Any medical or psychological conditions precluding informed consent
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of California, San FranciscoSan Francisco, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 12, 2023. Always confirm current availability with the study team.